Delivery Order 36C25720D0073-36C25721N0543

Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, received a delivery order modification from Veterans Integrated Service Network 17 (VISN 17) to deobligate funds from a pharmacy compounding contract. The original contract, awarded on August 17, 2021, carried a ceiling value of approximately $1.1M and was structured as a firm fixed-price delivery order with no set-aside designation. The work was performed in Amarillo, Texas, and the contract's ultimate completion date was May 31, 2024. Optum Pharmacy 801 specializes in advanced pharmaceutical compounding services for the Department of Veterans Affairs, including preparation of chemotherapy agents, hazardous sterile compounds, and patient-specific intravenous medications with 503A pharmacy certification.

This modification to deobligate funds represents a reduction in the contract's obligated amount and is consistent with the Department of Veterans Affairs' management of flexible procurement vehicles for specialized pharmaceutical services. As a critical supplier to the VA healthcare system, Optum Pharmacy 801 has secured multiple significant indefinite delivery contracts and blanket purchase agreements across various VISNs, enabling the agency to procure customized pharmaceutical compounding on an as-needed basis. The company's contract performance for the VA spans oncology support, hazardous drug handling, and sterile compounding services across multiple geographic regions and medical centers serving the veteran population.